seve333, given the current business situation or lack thereof, Amarin has no reason to be a publicly traded company. I consider its current status as a start-up company with no debt and tons of cash and patents. Private equity could make Denner an offer he can't refuse, take the company private repackage it find a buyer for V or merge into a company with some growth potential immediately accretive to the bottom line of the newly formed company. This will provide time for Vazkepa to become approved in ROW. I don't anticipate revenue growth for this company for a few years then maybe Wall St will take a second look at it. This company has 9 lives I think we're on the 7th live.
Or Denner should find a privately owned company with synergies to complement V. Going public is a huge expense for a private company we've got the cash and Amarin can issue some convertible preferred to the acquired company as they hit certain milestones Amarin can convert pfd into unregistered common with a one yr restriction plus it won't be dilutive to the parent company, Amarin. Just saying!
Market Data 
Markets 
AI
